Moulay Alaoui-Jamali

8PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 24, 2026
ALDH+ Anaplastic Thyroid Cancer Cells Show Vulnerability to a Pharmacologic Inducer of Centrosome Declustering.

|May 04, 2023
Discovery of a Small-Molecule Inhibitor Targeting the Androgen Receptor N-Terminal Domain for Castration-Resistant Prostate Cancer.

Qianhui Yi, Weiguo Liu, Jung Hwa Seo

|Apr 22, 2022
NEDD9 links anaplastic thyroid cancer stemness to chromosomal instability through integrated centrosome asymmetry and DNA sensing regulation.

Henry G Yu, Krikor Bijian, Sabrina D da Silva

|Feb 15, 2022
Novel Aurora A and Protein Kinase C (α, β1, β2, and θ) Multitarget Inhibitors: Impact of Selenium Atoms on the Potency and Selectivity.

Krikor Bijian, Dominik Wernic, Anita K Nivedha

|Sep 21, 2019
A Unique Morphological Phenotype in Chemoresistant Triple-Negative Breast Cancer Reveals Metabolic Reprogramming and PLIN4 Expression as a Molecular Vulnerability.

Isabelle Sirois, Adriana Aguilar-Mahecha, Josiane Lafleur

|Mar 17, 2019
SWI/SNF-Compromised Cancers Are Susceptible to Bromodomain Inhibitors.

Tatiana Shorstova, Maud Marques, Jie Su

Pageof 2

Frequent Collaborators

2 joint publications

Jie Su

1 joint publications

Sidong Huang

1 joint publications

Nicolas Moitessier

1 joint publications

Alan Spatz